Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/06/2012US20120308608 Interferon-inducing compounds and uses thereof
12/06/2012US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels
12/06/2012US20120308601 Methods and materials for treating cancer
12/06/2012US20120308593 Immunological Compositions for HIV
12/06/2012US20120308591 Tmem22 peptides and vaccines including the same
12/06/2012US20120308590 Imp-3 oligopeptides and vaccines including the same
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308569 Gene products differentially expressed in cancerous cells
12/06/2012US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/06/2012US20120308567 Use of tyrosine kinase inhibitors for treatment of prolactinoma
12/06/2012US20120308563 Regulatory b cells (tbregs) and their use
12/06/2012US20120308562 Methods of treating mesothelioma with a pi3k inhibitor compound
12/06/2012US20120308542 Method for Ameliorating or Preventing Arrhythmic Risk Associated with Cardiomyopathy by Improving Conduction Velocity
12/06/2012US20120308519 Anti-Arenaviral Compounds
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308517 Compositions for the treatment of infectious and tumoural diseases
12/06/2012US20120308516 Use of metallocene compounds for cancer treatment
12/06/2012US20120308511 Co-Therapy for Diabetic Conditions
12/06/2012US20120308510 Method, composition, and articles for improving joint lubrication
12/06/2012US20120308509 Method and Composition for In Situ Formation of an Artificial Blockage to Control Blood Loss
12/06/2012US20120308508 Microgel compositions
12/06/2012US20120308495 Photostabilization of coenzyme q compounds with alkoxycrylene compounds
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012US20120308479 Brain Endothelial Cell Expression Patterns
12/06/2012DE202005022066U1 Behandlung von Mastitis Treatment of mastitis
12/06/2012DE112010004862T5 Polymorphe Form von Nevirapin und deren Herstellung Polymorphic form of nevirapine and their preparation
12/06/2012DE102011104267A1 Verbindungen als PPAR beta/delta Inhibitoren für die Behandlung von PPAR beta/delta-vermittelten Erkrankungen Compounds as PPAR beta / delta inhibitors for the treatment of PPAR beta / delta-mediated diseases
12/06/2012DE102006053594C5 Verfahren zur Reinigung von Letrozol A process for purifying letrozole
12/06/2012CA2875025A1 Tricyclic inhibitors of poly(adp-ribose)polymerase
12/06/2012CA2843126A1 Clenbuterol for use in treatment of autism
12/06/2012CA2838179A1 Targeted delivery of retinoid compounds to the sebaceous glands
12/06/2012CA2838059A1 Method, composition, and articles for improving joint lubrication
12/06/2012CA2838023A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
12/06/2012CA2837882A1 (22e)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin d3 derivatives
12/06/2012CA2837759A1 Novel antibacterial combination therapy
12/06/2012CA2837758A1 Polymorphism panels predictive of anthracycline-induced cardiotoxicity (act)
12/06/2012CA2837747A1 A composition comprising at least one alginate for use in treatment and/or prevention of overweight
12/06/2012CA2837657A1 Compositions for sequential administration of opioid receptor agonists
12/06/2012CA2837630A1 Substituted aminoimidazopyridazines
12/06/2012CA2837627A1 Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
12/06/2012CA2837586A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837517A1 Imidazole derivatives
12/06/2012CA2837481A1 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
12/06/2012CA2837437A1 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
12/06/2012CA2837411A1 Rhamno-polysaccharide from enterococcus faecium clonal complex 17 and uses thereof
12/06/2012CA2837382A1 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders
12/06/2012CA2837381A1 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
12/06/2012CA2837359A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/06/2012CA2837341A1 Method of determining vasoreactivity using inhaled nitric oxide
12/06/2012CA2837266A1 Amorphous ritonavir co-precipitated
12/06/2012CA2837241A1 Composition and tablet comprising raltegravir
12/06/2012CA2837240A1 Ophthalmic preparation comprising a pgf2.alpha. analogue
12/06/2012CA2837232A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
12/06/2012CA2837227A1 Novel immune system modulators
12/06/2012CA2837207A1 Novel immune system modulators
12/06/2012CA2837176A1 Stable liquid formulation of etanercept
12/06/2012CA2837167A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837084A1 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use
12/06/2012CA2837042A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
12/06/2012CA2836904A1 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012CA2836394A1 Novel ticagrelor co - crystal
12/06/2012CA2836362A1 Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids
12/06/2012CA2836202A1 Imidazopyridine compounds
12/06/2012CA2836025A1 Nasal pharmaceutical formulation comprising fluticasone
12/06/2012CA2835981A1 Process for the production of estetrol intermediates
12/06/2012CA2835979A1 Process for the production of estetrol intermediates
12/06/2012CA2835963A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012CA2835916A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
12/06/2012CA2835907A1 Compositions comprising antibacterial agent and tazobactam
12/06/2012CA2835760A1 Methods of treating mesothelioma with a pi3k inhibitor compound
12/06/2012CA2835758A1 Wash composition
12/06/2012CA2835715A1 Anti-inflammatory composition
12/06/2012CA2835272A1 Pharmaceutical antiretroviral composition
12/06/2012CA2835220A1 Neprilysin inhibitors
12/06/2012CA2835216A1 Neprilysin inhibitors
12/06/2012CA2834742A1 A method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
12/06/2012CA2834194A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
12/06/2012CA2833813A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
12/05/2012EP2530157A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
12/05/2012EP2530156A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530155A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530154A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530153A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530152A1 Reduction of off-target RNA interference toxicity
12/05/2012EP2530083A1 Inhibitors of bruton's tyrosine kinase
12/05/2012EP2530081A2 Nilotinib HCI crystalline forms
12/05/2012EP2530080A1 Method for manufacturing polymethoxyflavones that are highly stable over time and have reduced residual pesticide levels
12/05/2012EP2530079A1 Phenyl c-glucoside derivatives, preparation methods and uses thereof
12/05/2012EP2530078A1 Thiazole derivative
12/05/2012EP2530075A2 Modulators of ATP-binding cassette transporters
12/05/2012EP2530072A1 New compounds, synthesis and use thereof in the treatment of pain
12/05/2012EP2530068A1 New strontium salts, synthesis and use thereof in the treatment of osteoporosis
12/05/2012EP2529793A2 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
12/05/2012EP2529757A1 Paliperidone implant formulation
12/05/2012EP2529756A2 Risperidone and/or Paliperidone implant formulation
12/05/2012EP2529755A1 Pharmaceutical composition and preparation for oral administration
1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 7860